AbbVie
ABBV
ABBV
1,432 hedge funds and large institutions have $58.2B invested in AbbVie in 2013 Q4 according to their latest regulatory filings, with 191 funds opening new positions, 453 increasing their positions, 605 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 1,295 → 1,432 (+137)
0.04% more ownership
Funds ownership: 68.99% → 69.03% (+0.04%)
25% less repeat investments, than reductions
Existing positions increased: 453 | Existing positions reduced: 605
Holders
1,432
Holding in Top 10
59
Calls
$411M
Puts
$211M
Top Buyers
| 1 | +$695M | |
| 2 | +$225M | |
| 3 | +$224M | |
| 4 |
Morgan Stanley
New York
|
+$186M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$151M |
Top Sellers
| 1 | -$355M | |
| 2 | -$254M | |
| 3 | -$217M | |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$196M |
| 5 |
JPMorgan Chase & Co
New York
|
-$159M |